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Respiratory and systemic humoral and cellular immune
responses of pigs to a heterosubtypic influenza A virus
infection
Paul P. Heinen, Els A. de Boer-Luijtze and Andre T. J. Bianchi
Department of Mammalian Virology, Institute for Animal Science and Health (ID-Lelystad BV), PO Box 65, 8200 AB Lelystad,
The Netherlands
The level of heterosubtypic immunity (Het-I) and the immune mechanisms stimulated by a
heterosubtypic influenza virus infection were investigated in pigs. Pigs are natural hosts for
influenza virus and, like humans, they host both subtypes H1N1 and H3N2. Marked Het-I was
observed when pigs were infected with H1N1 and subsequently challenged with H3N2. After
challenge with H3N2, pigs infected earlier with H1N1 did not develop fever and showed reduced
virus excretion compared with non-immune control pigs. In addition, virus transmission to
unchallenged group-mates could be shown by virus isolation in the non-immune control group but
not in the group infected previously with H1N1. Pigs infected previously with homologous H3N2
virus were protected completely. After challenge with H3N2, pigs infected previously with H1N1
showed a considerable increase in serum IgG titre to the conserved extracellular domain of M2 but
not to the conserved nucleoprotein. These results suggest that antibodies against external
conserved epitopes can have an important role in broad-spectrum immunity. After primary
infection with both H1N1 and H3N2, a long-lived increase was observed in the percentage of CD8M
T cells in the lungs and in the lymphoproliferation response in the blood. Upon challenge with
H3N2, pigs infected previously with H1N1 again showed an increase in the percentage of CD8M T
cells in the lungs, whereas pigs infected previously with H3N2 did not, suggesting that CD8M T cells
also have a role in Het-I. To confer broad-spectrum immunity, future vaccines should induce
antibodies and CD8M T cells against conserved antigens.
Introduction
Influenza A virus expresses on its membrane two immuno-
genic, but variable proteins, haemagglutinin (HA) and neur-
aminidase (NA). In humans, new epidemic strains arise every
1–2 years as a result of selected point mutations in these two
surface glycoproteins, a phenomenon known as antigenic drift.
Sometimes, an exchange of the HA and}or NA gene segment
with an animal virus occurs, a phenomenon known as antigenic
shift, and this may result in a pandemic. Current human
influenza vaccines are updated annually to induce immune
responses specific for the prevalent strains.
Antigenic drift is generally ascribed to immune pressure, i.e.
the influence of antibodies induced by a previous infection, or
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by vaccination. In pigs, antigenic drift of influenza viruses
seems to be more limited than in humans (Brown et al.,
1997 ; Bikour et al., 1995 ; Castrucci et al., 1994). This is
probably because pigs have a short life span, which does not
cover more than one influenza epidemic, and vaccines are only
infrequently applied. Nevertheless, antigenic drift of swine
influenza A H3N2 viruses was demonstrated in the
Netherlands and Belgium. This drift has led to a loss of cross-
reactivity of recent field isolates with the human A}Port
Chalmers}1}73 (H3N2) strain, which is the strain in the
current swine influenza vaccine. Therefore, replacement of this
strain by a more recent swine H3N2 isolate was recommended
(de Jong et al., 1999). However, the regular updating of
influenza vaccines is costly and impractical. Antigenic shifts
occur frequently in pigs (Castrucci et al., 1993 ; Brown et al.,
1998 ; Zhou et al., 1999), probably because pigs are highly
susceptible to infection and have cell-surface receptors for
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viruses of both avian and human origin (Ito et al., 1998).
Moreover, it is conceivable that, if vaccines were to be applied
more widely, acceleration of antigenic drift and antigenic shifts
would soon give rise to escape variants.
Instead of the regular updating of vaccine strains, it might
be possible to induce broadly reactive immune responses that
could provide protection when the vaccine does not match
circulating strains, perhaps even against a new subtype.
Broadly reactive responses against influenza A virus have been
studied extensively in mice (Kurimura & Hirano, 1973 ; Okuno
et al., 1994 ; Smirnov et al., 1999 ; Webster & Askonas,
1980 ; Wraith & Askonas, 1985). Infection of mice with an
influenza A virus of one subtype can induce partial protection
against an infection with a virus of a different subtype (Epstein
et al., 1997 ; Flynn et al., 1998 ; Liang et al., 1994 ; Nguyen et al.,
1999 ; Schulman & Kilbourne, 1965 ; Werner, 1966). However,
the immune mechanisms responsible for this broad protection,
termed heterosubtypic immunity (Het-I), are still incompletely
defined.
In this study, the level of Het-I to infection with an H3N2
virus after primary infection with an H1N1 virus and the
immune mechanisms stimulated were investigated in pigs. The
H3N2 virus was transmitted from humans to pigs during the
1968 Hong Kong pandemic and the H1N1 virus from birds
to pigs in Northern Europe in 1979. In 1984, a genetic
reassortment between the two subtypes occurred, resulting in
an H3N2 virus carrying all the proteins of the avian H1N1
virus except for HA and NA (Castrucci et al., 1993). Since then,
the unchanged avian H1N1 virus and the reassortant human
H3N2 virus have continued to co-circulate in the swine
population in Europe. The fact that all proteins except for HA
and NA are very similar between the two subtypes makes
these European swine viruses ideal to study Het-I.
Methods
+ Propagation of influenza virus. The influenza virus strains
A}Sw}Best}96 (H1N1) and A}Sw}Oedenrode}96 (H3N2) were iso-
lated from pneumonic lung tissue of pigs from outbreaks of influenza
during a recent field survey (Loeffen et al., 1999). These viruses were
isolated in primary cultures of porcine thyroid cells and then passaged
three times in these cells and then twice in Madin–Darby canine kidney
(MDCK, ECACC no. 84121903) cells. Virus stocks were produced and
stored at fi70 °C until used as inoculum or as antigen in haemag-
glutination inhibition (HI) assays, ELISAs and T-cell proliferation assays.
+ Pigs, immunization and challenge. Thirty Dutch Landrace pigs
were obtained from the specific-pathogen-free herd of the Institute for
Animal Science and Health. The pigs were divided into three groups of
10 and each group was housed in a separate room. At the age of 10
weeks, pigs were inoculated with live virus, in the nostrils, with an
aerosol produced by nebulization of 2 ml culture supernatant, using an
airbrush device (model no. 100LG; Badger). Pigs in the Het-I group were
immunized with 10) TCID
&!
of the field isolate A}Sw}Best}96 (H1N1).
Pigs in the homologous immunity (Hom-I) group were immunized with
A}Sw}Oedenrode}96 (H3N2). Pigs in the control group were inoculated
with uninfected culture supernatant and were used as challenge controls.
At day 42 post-inoculation (p.i.), 6 weeks after primary infection, five of
the pigs in each group were challenged with an aerosol of the field isolate
A}Sw}Oedenrode}96 (H3N2). The other five pigs of each group were
kept apart for 24 h and then reunited with their challenged group-mates
to determine whether virus transmission occurred in the presence of
Hom-I and Het-I and in the absence of immunity. The experiment was
approved by the institute’s ethical committee for experiments in animals.
+ Clinical observations and sampling of pigs. Rectal
temperatures of all pigs were measured with a thermometer (C 402
Terumo Digital Clinical, Vetin-Aacofarma) and oropharyngeal fluid was
collected daily for 8 days following primary infection (days 0–8 p.i.) and
challenge inoculation (days 42–50 p.i.). Blood was collected from the five
challenged pigs at days 0, 3, 7, 10, 18, 25, 31, 38, 46, 50, 53 and 59 p.i.
and from the five contact pigs at days 38, 46, 50, 53 and 59 p.i. Serum was
collected to determine HI antibody titres in the HI assay and titres of IgG
antibodies specific for the extracellular domain of M2 (M2e) and for the
nucleoprotein (NP) in ELISAs. Heparinized blood was collected for the
isolation of peripheral blood mononuclear cells (PBMC) to be used in a T-
cell proliferation assay. Bronchoalveolar lavage fluid (BALF) and nasal
swabs (NS) (Medical Wire & Equipment Co.) of the challenged pigs were
collected at days 0, 2, 4, 8, 11, 15, 22, 29, 39, 44, 46, 50, 53 and 57 p.i.
To collect NS and BALF, animals were anaesthetized by injection
(ketamine, midazolam, medetomidine). To avoid excessive interference
with virus transmission, no BALF was collected from the contact pigs. NS
was collected to determine antibody titres in the anti-NP IgA ELISA and
BALF to monitor the changes in phenotypes of BALF cells by flow
cytometry.
+ Virus isolation. Tenfold serial dilutions, starting at a dilution of
1 :10, of oropharyngeal fluid were prepared in cell culture infection
medium (McCoy’s medium without serum, supplemented with 5 lg}ml
trypsin). Dilutions were inoculated on MDCK cells in microtitre plates,
which were incubated at 37 °C and examined for cytopathic effect after
4 days. Of the samples that were negative in the microtitre assay, 1 ml
was tested for the presence of virus by inoculating a monolayer in 25 ml
tissue culture flasks. Virus titres were calculated by the Spearman–Ka$ rber
method.
+ HI assay. The HI assay was performed essentially as described
previously (Kendal et al., 1982) using 0–5% chicken erythrocytes for
haemagglutination and four haemagglutinating units of A}Sw}Best}96
(H1N1) or A}Sw}Oedenrode}96 (H3N2).
+ ELISA for IgG specific for M2e. The sequence encoding the
complete M2 protein was determined for A}Sw}Best}96 (H1N1) and
A}Sw}Oedenrode}96 (H3N2). The first 25 N-terminal amino acid
residues that form the extracellular domain of the M2 protein (M2e) were
the same for both subtypes. A synthetic peptide with the amino acid
sequence MSLLTEVETPTRNGWECRY was made and a conjugate of
this peptide with keyhole lipid haemocyanin was used to coat 96-well
ELISA plates (Costar EIA}RIA). Plates were then blocked with 1% BSA
in PBS, incubated with 2-fold serial dilutions of serum samples starting at
a dilution of 1 :20, incubated with a MAb against swine IgG1 (23.49.1)
conjugated to HRP and then incubated at room temperature with
chromogen}substrate solution. The absorbance at 450 nm was read with
an ELISA reader (Spectra Reader, SLT Labinstruments) and antibody
titres were expressed as the reciprocal of the sample dilution still giving
an absorbance of 1–0.
+ ELISAs for IgG and IgA specific for NP. ELISAs to measure
influenza virus NP-specific IgG and IgA antibodies in pigs were described
recently (Heinen et al., 2000). Absorbance and antibody titres were
determined as described for the anti-M2e IgG ELISA.
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+ Flow cytometric analysis of BALF cells. The technique that was
used to obtain BALF was described previously (van Leengoed & Kamp,
1989). Approximately 30 ml PBS was added to the BALF to give a total
volume of 50 ml. BALF cells were collected by centrifugation at 300 g for
10 min at 4 °C and washed once with 50 ml PBS. Cells were then
suspended in 1 ml PBS containing 2% heat-inactivated bovine serum and
0–01% sodium azide (FACS buffer) and the total number of recovered
cells was determined. Cells were spun down in 96-well U-bottomed
microtitre plates by centrifugation at 230 g for 3 min. The supernatant
was discarded and the cells were incubated for 30 min on ice with various
combinations of MAbs to leukocyte differentiation antigens. The MAbs
used to differentiate myeloid cells were directed against the following cell
markers : SWC3 (clone 74-22-15, IgG
"
), MHC II (clone MSA3, IgG2a),
CD14 (clone MY4, Ig2b) (Coulter) and CD163 (clone CVI 517.2, IgG2b).
The MAbs used to differentiate lymphoid cells were directed against
CD2 (clone MSA4, IgG2a), CD3 (clone ppt3, IgG1), CD4 (clone 74-12-
4, IgG2b), CD5 (clone b53b7, IgG1), CD6 (clone a38b2, IgG1), CD8
(clone 295}33, IgG2a) and cdT cell receptor (TCR-cd) (clone ppt16,
IgG2b). These MAbs were used previously to analyse changes in the
phenotype of leukocytes in the BALF of pigs infected with porcine
reproductive and respiratory syndrome virus (Samsom et al., 2000). After
incubation, the cells were washed three times with FACS buffer and then
incubated for 30 min on ice with the appropriate FITC- or PE-conjugated
goat anti-mouse IgG isotype-specific antibodies, diluted in FACS buffer.
Subsequently, the cells were washed three times, re-suspended in FACS
buffer and transferred to tubes. Fluorescence was measured using a
FACScan flow cytometer (Becton Dickinson).
+ T-cell proliferation assay. The T-cell proliferation assay to
measure influenza virus-specific T-cell responses of pigs was performed
essentially as described for pseudorabies virus (Kimman et al., 1995).
Briefly, PBMC were isolated from heparinized blood samples by
centrifugation onto Lymphoprep (Nycomed Pharma A), and were washed
twice with PBS. The isolated PBMC were seeded in 96-well flat-bottom
plates (M29, Greiner) at a density of 5‹10& cells per well in 100 ll
medium (RPMI 1640 containing 10% porcine serum, 2 mM l-glutamine,
50 lM b-mercaptoethanol, 200 U}ml penicillin, 200 lg}ml strepto-
mycin and 100 U}ml mycostatin). To the PBMC, 100 ll medium
containing 10& TCID
&!
influenza A}Sw}Best}96 (H1N1) or
A}Sw}Oedenrode}96 (H3N2), a control sample prepared from non-
infected cells (mock control) or 5 lg}ml concanavalin A (vitality control)
were added in quadruplicate. After 4 days of incubation at 37 °C in a 5%
CO
#
atmosphere, the cultures were pulsed with 0–4 lCi [$H]thymidine
(Amersham). After 4 h of incubation, cells were harvested and the
incorporated radioactivity was measured in a Betaplate scintillation
counter (Wallac). Proliferation was expressed as the number of counts
(mean of quadruplicate) of influenza virus-stimulated PBMC minus the
number of counts of the mock control-stimulated PBMC (Dc.p.m.).
Results
Clinical signs and virus excretion
Primary inoculation of pigs by aerosol with 10) TCID
&!
A}Sw}Oedenrode}96 (H3N2) or A}Sw}Best}96 (H1N1)
virus into the nostrils caused acute disease. Eight of ten H3N2-
inoculated pigs and all H1N1-inoculated pigs developed fever
(& 40 °C) for at least 1 day between day 1 and day 6 p.i.
Infection with the H1N1 virus was more severe than with the
H3N2 virus, as more pigs had fever for a longer time. Mean
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Fig. 1. (a) Mean temperatures of control pigs (+) and pigs infected with
influenza virus A/Sw/Best/96 (H1N1) (E) or A/Sw/Oedenrode/96
(H3N2) (_) (nfl10). Later, of the 10 pigs in each group, five were
challenged and five were used as contact pigs. Contact pigs were
separated before their group-mates were challenged and were then
reunited after 24 h. (b) Mean temperatures of pigs after challenge with
influenza A/Sw/Oedenrode/96 (H3N2) virus, 6 weeks after primary
infection with A/Sw/Best/96 (H1N1) (E) or A/Sw/Oedenrode/96
(H3N2) (_) and of non-immune control pigs (+). Results are presented
as means‡SD (nfl5). Only temperatures of challenged pigs are
presented. No fever was detected in the contact pigs in any of the three
groups. p.c., Post-challenge.
temperatures of all pigs are presented (Fig. 1a). In both groups,
pigs excreted virus for 5 or 6 days after infection (Table 1).
After challenge inoculation with H3N2 at day 42 p.i., fever
was measured in each of the five challenged pigs in the control
group but not in the groups that were previously immunized
with H1N1 (Het-I group) or H3N2 (Hom-I group) (Fig. 1b). In
addition, virus excretion and transmission to the contact
animals was reduced in the Het-I group compared with the
control group (Table 1), indicating that infection with H1N1
confers heterosubtypic protection against infection with
H3N2. Pigs in the Hom-I group did not excrete any virus after
challenge.
No fever was detected in the contact pigs in the Hom-I or
in the Het-I group or in the contact pigs of the control group
(data not shown).
HI responses
No cross-reactivity of HI antibodies from H1N1-infected
pigs was observed with the H3N2 virus, or vice versa, after
primary infection (Fig. 2a, b).
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Table 1. Virus titres in oropharyngeal swabs of pigs after primary infection with A/Sw/Best/96 (H1N1) or A/Sw/Oedenrode/96 (H3N2) and after
subsequent challenge of pigs with A/Sw/Oedenrode/96 (H3N2)
Titres are given as log
"!
(TCID
&!
}ml). ! 1–6, Virus detected in 1 ml sample ; –, no virus detected. Day 1 post-challenge is day 43 p.i.
Time (days p.i.) Time (days post-challenge)
Animal 1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8
A/Sw/Best/96 (H1N1)
1 4–4 – 3–6 ! 1–6 2–1 ! 1–6 – – 2–6 ! 1–6 – – – – – –
2 2–5 ! 1–6 ! 1–6 2–5 2–8 ! 1–6 – – – ! 1–6 – – – – – –
3 4–6 ! 1–6 ! 1–6 ! 1–6 3–2 – – – ! 1–6 ! 1–6 – – – – – –
4 2–6 – ! 1–6 ! 1–6 ! 1–6 – – – ! 1–6 – – – – – – –
5 2–3 ! 1–6 2–3 ! 1–6 ! 1–6 – – – ! 1–6 ! 1–6 – – – – – –
A/Sw/Oedenrode/96 (H3N2)
1 2–5 – 2–6 – 2–6 – – – – – – – – – – –
2 3–4 – ! 1–6 2–3 ! 1–6 ! 1–6 – – – – – – – – – –
3 2–7 ! 1–6 ! 1–6 ! 1–6 ! 1–6 – – – – – – – – – – –
4 3–3 2–2 2–3 ! 1–6 ! 1–6 ! 1–6 – – – – – – – – – –
5 2–1 ! 1–6 ! 1–6 2–6 ! 1–6 – – – – – – – – – – –
Non-immunized controls
Challenged pigs
1 ! 1–6 ! 1–6 ! 1–6 ! 1–6 ! 1–6 – – –
2 ! 1–6 ! 1–6 ! 1–6 – – – – –
3 ! 1–6 ! 1–6 – ! 1–6 – – – –
4 2–7 – 3–7 – – – – –
5 2–5 – – – – – – –
Contact pigs*
6 – – ! 1–6 – ! 1–6 2–0 – –
7 – – ! 1–6 ! 1–6 – ! 1–6 – –
8 – – ! 1–6 – – – – –
9 – – 2–6 – – – – –
10 – – 2–6 – – ! 1–6 – –
* Virus was only detected in contact pigs in the non-immunized control group and not in contact pigs in the other groups. The five contact pigs were separated before their group-mates
were challenged and were then reunited after 24 h.
C
H
A
A
Heterosubtypic immunity of pigs to influenza
H
I 
ti
tr
e
0
Time (days p.i.)
(a)
10 20 30 40 50 60
10
100
1000
10 000
H
I 
ti
tr
e
0
Time (days p.i.)
(b)
10 20 30 40 50 60
10
100
1000
10 000
A/Sw/Oedenrode/96 (H3N2)
A/Sw/Best/96 (H1N1)
Fig. 2. Mean HI titres against the virus strains A/Sw/Oedenrode/96
(H3N2) (a) and A/Sw/Best/96 (H1N1) (b) in serum of pigs. At day
0 p.i., pigs were inoculated with 108 TCID50 A/Sw/Best/96 (H1N1) (E)
or A/Sw/Oedenrode/96 (H3N2) (_) or with non-infected cell
supernatant (+). At day 42 p.i., pigs were challenged with
A/Sw/Oedenrode/96 (H3N2). Open symbols represent contact pigs in
the three groups. Contact pigs were separated before their group-mates
were challenged and were then reunited after 24 h. Results are presented
as means‡SD (nfl5).
After challenge, the challenged pigs in the Het-I group
developed an H3N2-specific HI response that was very similar,
in both kinetics and magnitude, to the response developed by
the non-immune control pigs (Fig. 2a). However, contact pigs
in the Het-I group showed no detectable HI response (2}5) or
only a very low HI response (3}5).
A slight increase was also observed in the HI titre in the
challenged pigs in theHet-I group toH1N1 (Fig. 2b), indicating
that some cross-reactive HI antibodies were produced after
heterosubtypic infection.
M2e-specific serum IgG response and NP-specific
serum IgG and nasal IgA response
After primary infection with H1N1 or H3N2, a low IgG
response to M2e was observed. This response was 3-fold
higher after H1N1 infection than after H3N2 infection, which
was also observed for the anti-NP IgG response. After
challenge, the anti-M2e titre increased 25-fold in the
challenged pigs in the Het-I group, whereas it did not increase
in the Hom-I group (Fig. 3a). This strong IgG booster response
in the Het-I group against M2e was not observed against the
conserved NP. No increase in the M2e IgG titre was observed
in the contact pigs in the Het-I group.
The kinetics of the NP-specific IgG and IgA antibody
responses after primary infection with H1N1 were very similar
to those seen after infection with H3N2. However, H1N1-
infected pigs showed a higher serum IgG response (Fig. 3b),
whereas H3N2-infected pigs showed a higher nasal IgA
response (Fig. 3 c).
After challenge infection with H3N2, a slight secondary
NP-specific IgG response in the challenged pigs was observed
in the Het-I group but not in the Hom-I group (Fig. 3b). No
secondary IgG response was detected in the contact pigs of the
Het-I group.
After challenge infection, a secondary IgA response was
observed in the Het-I group, which was stronger than that in
the Hom-I group (Fig. 3 c). No secondary IgA response was
observed in the contact pigs of the Hom-I group or in the Het-
I group.
Flow cytometric analysis of BALF cells
With the MAbs used, two phenotypes of myeloid cells
were differentiated : SWC3+ CD163− CD14+ MHCII− cells
(neutrophil phenotype) and SWC3+ CD163+ CD14+ MHCII+
cells (monocyte and macrophage phenotype) (Fig. 4a).
By comparing the kinetics and percentages of lymphoid
cells stained with all combinations of MAbs, five phenotypes
of lymphoid cells were distinguished. These five phenotypes
could all be seen separately when a combination of MAbs
against CD5 and CD8 was used (Fig. 4b). The lymphoid
phenotypes were : CD2+ CD3− CD4− CD5− CD6− CD8low
TCR-cd− (NK phenotype), CD2+ CD3+ CD4− CD5+ CD6+
CD8high TCR-cd− (CTL phenotype), CD2+ CD3+ CD4+
CD5high CD6+ CD8−/low TCR-cd− (Th phenotype), CD2+
CD3+ CD4− CD5low CD6− CD8−/low TCR-cd+ (TCR-cd+ T-
cell phenotype) and a heterogeneous population of CD5−
CD8− cells (fi}fi T cells).
As reported previously (Samsom et al., 2000), a population
of large, highly autofluorescent cells (LHAC) and a population
of small, low-autofluorescent cells (SLAC) were distinguished
and these were analysed separately (Fig. 4a). It was shown that
the LHAC consisted solely of myeloid (SWC3+) cells.
However, a large proportion of the SLAC at days 2 and 4 after
infection was also SWC3+. These were SWC3+ CD163−
neutrophils, which massively infiltrated the lung (Fig. 4a), as
described previously (Haesebrouck & Pensaert, 1986 ; Van
Reeth et al., 1999). Corrections were therefore made such that
the neutrophils were subtracted from the lymphoid population
and added to the myeloid population and the percentages of
the different cell phenotypes within the two populations could
be calculated. Because the cell numbers collected from the
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Fig. 3. Mean serum IgG antibody response to M2e (a)
and mean serum IgG (b) and nasal IgA (c) antibody
responses of pigs to NP. At day 0 p.i., pigs were
inoculated with 108 TCID50 A/Sw/Best/96 (H1N1) (E)
or A/Sw/Oedenrode/96 (H3N2) (_) or with non-
infected cell supernatant (+). At day 42 p.i., pigs were
challenged with A/Sw/Oedenrode/96 (H3N2). Open
symbols represent contact animals in the three groups
(nfl5). Contact pigs were separated before their group-
mates were challenged and were then reunited after 24 h.
Results are presented as means‡SD (nfl5).
BALF of pigs varied too much between samples, we did not use
the cell counts to calculate the absolute numbers of cells of each
phenotype.
All changes in the phenotype of the BALF myeloid and
lymphoid leukocyte populations after primary and secondary
infection of the pigs are shown (Fig. 5a, b). After primary
infection with H1N1 or H3N2, an acute inflammatory response
characterized by a massive increase of neutrophils from 6 to
40% (day 2 p.i.) of all leukocytes in the lungs was observed.
After challenge, the infiltration was the same in the non-
immune control group, reduced in the Het-I group and absent
in the Hom-I group (Fig. 5a).
From day 8 p.i., the percentage of lymphocytes in the lungs
of both H1N1- and H3N2-infected pigs was higher than in the
control pigs and remained elevated until day 42 p.i. Further
analysis of the different phenotypes within the lymphocyte
population shows the following sequence of events after
H3N2 infection : (i) an increase in the percentage of NK cells
starting at day 2 p.i., (ii) a peak in percentage of Th cells
between days 4 and 11 p.i., (iii) a massive infiltration of CTLs
on day 8 p.i., leading to a decrease in the percentage of NK
cells at this time-point, (iv) the temporary disappearance of the
CTLs from the lungs around day 11 p.i. and (v) a long-lived
increase in the percentage of CTLs in the lungs and the
decrease in NK cells to the pre-infection level. The same
sequence of events was also observed after H1N1 infection,
but developed faster than after H3N2 infection (Fig. 5b).
Upon challenge infection on day 42 p.i., a second increase
in the percentage of CTLs was observed in the Het-I group but
not in the Hom-I group. The secondary infiltration of CTLs
after H3N2 challenge infection (day 42 p.i.) in the Het-I group
was not observed to be any faster than after primary infection
in the control group, and even later than after primary H1N1
infection (day 0 p.i.) (Fig. 5b).
Influenza virus-specific T-cell response
After infection with both H1N1 and H3N2, an influenza
virus-specific T-cell response of PBMC was measured in the
lymphoproliferation assay from day 7 p.i. onwards (Fig.
6a). The T-cell proliferation was partially subtype-specific.
PBMC of pigs infected with H1N1 virus showed a higher
response when stimulated with A}Sw}Best}96 (H1N1) than
with A}Sw}Oedenrode}96 (H3N2), while the opposite was
true for PBMC of pigs infected with H3N2 (Fig. 6a, b).
Upon secondary challenge infection on day 42 p.i., an
increase in the T-cell proliferation response was observed in
the Het-I group but not in the Hom-I group. In both the
challenged pigs (Fig. 6a) and the contact pigs (Fig. 6b) in the
Het-I group, a secondary lymphoproliferation response was
observed.
The vitality of PBMC was the same throughout the
experimental period in all groups.
Discussion
Heterosubtypic immunity (Het-I), the immunity induced by
infection with an influenza virus of one subtype against a
subsequent infection with a virus of another subtype, has been
observed in mice (Epstein et al., 1997 ; Flynn et al., 1998 ; Liang
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(a)
(b)
Fig. 4. (a) Flow cytometry analysis of leukocytes collected from the lungs of pigs. Plots show the two gates separating the
lymphocytes from other leukocytes (I) and the percentage of SWC3+ CD163− neutrophils in the lungs of non-immune pigs, 2
days after inoculation with non-infected cell supernatant (II) or influenza virus-infected cell supernatant (III). (b) Flow cytometry
analysis of lymphocytes collected from the lungs of pigs after inoculation with non-infected cell supernatant (I), primary
inoculation with 108 TCID50 A/Sw/Best/96 (H1N1) (II) and subsequent challenge with A/Sw/Oedenrode/96 (H3N2) (III).
Cells were double-stained with MAbs directed against CD5 and CD8. These plots of representative samples clearly show the
infiltration of CD5+ CD8high CTLs.
et al., 1994 ; Nguyen et al., 1999). In humans, it was shown to
be weak (Steinhoff et al., 1993), although occasional examples
have been reported (Sonoguchi et al., 1985). Here, we report
the existence of clear Het-I in pigs, using swine viruses of two
subtypes that are currently co-circulating in the pig population
in Europe. Infection with a swine influenza virus of subtype
H1N1 was shown to protect pigs partially against infection
with a virus of subtype H3N2. After challenge with H3N2,
pigs infected previously with H1N1 did not get fever and
showed reduced virus excretion compared with non-immune
control pigs. As a consequence, less virus was transmitted to
the unchallenged group-mates and virus excretion by these
pigs could not be detected by virus isolation. Although Het-I
does not provide the complete protection against infection
seen with Hom-I, it could be sufficient to halt the spread of an
influenza virus infection in a pig population in the field.
The predominant role of HA- and NA-specific virus-
neutralizing IgA and IgG antibodies in protection against
secondary infection with a homologous influenza A virus is
well established. However, the immune mechanisms respon-
sible for Het-I are incompletely defined. In the present study,
the responses of different immune mechanisms to primary and
secondary infection were monitored to gain insight into the
immunity underlying the suboptimal protection against in-
fection with a heterologous or, in our case, heterosubtypic
virus. This insight might suggest approaches to enhance the
induction by vaccination of responses leading to broad
protection.
HI antibodies after infection with H1N1 did not cross-react
with the H3N2 virus in the HI assay and, therefore, pre-
challenge HI antibodies do not seem to be responsible for the
observed Het-I. However, after challenge with H3N2, an
increase in HI titre was also observed against H1N1, which
suggests that cross-reactive HI antibodies are produced. HA-
specific virus-neutralizing antibodies that cross-react between
subtypes have been reported (Okuno et al., 1994 ; Smirnov et
al., 1999). In addition, helper T cells specific for influenza virus
internal proteins can enhance the HI antibody response (Russell
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Fig. 5. (a) Changes in the leukocyte population in the lungs of pigs (nfl5). At day 0 p.i., pigs were inoculated with 108
TCID50 A/Sw/Best/96 (H1N1) (D) or A/Sw/Oedenrode/96 (H3N2) (_) or with non-infected cell supernatant (*). At day
42 p.i., pigs were challenged with A/Sw/Oedenrode/96 (H3N2). (b) Changes in the lymphocyte population in the lungs of
pigs (nfl5). At day 0 p.i., pigs were inoculated with 108 TCID50 A/Sw/Best/96 (H1N1) (D) or A/Sw/Oedenrode/96 (H3N2)
(_) or with non-infected cell supernatant (*). At day 42 p.i., pigs were challenged with A/Sw/Oedenrode/96 (H3N2).
Results are presented as means‡SD (nfl5).
& Liew, 1979). In this manner, subtype-specific antibodies will
be produced faster and can contribute to Het-I, in addition to
cross-reactive antibodies. In the present study, the kinetics and
magnitude of the H3-specific HI antibody response after
challenge of pigs in the Het-I group was the same as in the non-
immune control group, which seems to disagree with this
concept. However, pre-existing immunity can enhance the
response to challenge infection, but can also inhibit the
response by reducing antigen exposure. Therefore, it is difficult
to compare the response to challenge infection with the
response to injection with a fixed quantity of antigen, as
studied by Russell & Liew (1979).
Interestingly, the antibody response to the conserved
extracellular domain of the M2 protein (M2e) was clearly
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Fig. 6. (a) Mean influenza virus-specific lymphocyte proliferation
responses of PBMC of pigs when stimulated with A/Sw/Oedenrode/96
(H3N2) (closed symbols) or A/Sw/Best/96 (H1N1) (open symbols). At
day 0 p.i., pigs were inoculated with 108 TCID50 A/Sw/Best/96 (H1N1)
(E, D) or A/Sw/Oedenrode/96 (H3N2) (_, ^) or with non-infected
cell supernatant (+, *). At day 42 p.i., pigs were challenged with
A/Sw/Oedenrode/96 (H3N2). (b) Mean influenza virus-specific
lymphocyte proliferation responses of PBMC of contact pigs in the three
groups. Contact pigs were separated before their group-mates were
challenged and were then reunited after 24 h. Results are presented as
means‡SD (nfl5).
boosted by the heterosubtypic infection, as the serum anti-
M2e antibody titre increased 25-fold between day 4 and day 8
post-challenge. In comparison, the antibody titre to the also
conserved NP only increased 2-fold. Therapeutic treatment
with an M2e-specific MAb was shown to reduce pulmonary
virus titres 100- to 1000-fold in mice (Mozdzanowska et al.,
1999 ; Treanor et al., 1990). It is therefore conceivable that pre-
and post-challenge anti-M2e antibodies play a significant role
in the early reduction of virus replication. The M2-specific
antibody response in convalescent humans has been reported
to be low and not consistently detectable (Black et al., 1993).
The present study shows that, in pigs, the anti-M2e antibody
response to a primary influenza virus infection is indeed low
compared with the response after heterosubtypic infection.
The current porcine vaccine does not induce a detectable anti-
M2e antibody response (unpublished result). Enhancement
of the anti-M2e response by vaccination may provide in-
creased Het-I, as was suggested previously for humans
(Mozdzanowska et al., 1999 ; Treanor et al., 1990). Interestingly,
it was shown that, in the proper circumstances, vaccination
with the extracellular domain of the M2 protein in the absence
of other influenza virus proteins can reduce virus infection in
mice (Neirynck et al., 1999).
The percentage of CD8+ CTLs in the lungs of pigs
increased from approximately 10% before primary infection to
more than 30% after primary infection and more than 50%
after secondary infection. The secondary challenge only
increased the percentage of CTLs in the lungs of hetero-
subtypically immune pigs, indicating that CTLs play a role in
Het-I. The CD8+ T cell arm of the cellular response has been
proposed to be the major mediator of Het-I, and many studies
have indeed proved that CTLs contribute to protection in mice
(Epstein et al., 2000 ; Mozdzanowska et al., 2000 ; Topham &
Doherty, 1998 ; Ulmer et al., 1998). A large proportion of these
cells recognizes conserved epitopes of NP. More than 15% of
CTLs in the lungs after primary infection and more than 65 %
after heterosubtypic challenge were shown to be specific
for the immunodominant NP
$’’
–
$(%
peptide (Doherty &
Christensen, 2000 ; Flynn et al., 1998, 1999). Moreover,
challenge was performed 7 months after priming of mice,
removing any concern that CTL memory is of short duration.
However, it was also shown that the secondary CTL response
develops in the mesenteric lymph nodes and that it takes at
least 4–5 days before the effectors are available in the infected
respiratory tract of mice. In the present study, the infiltration of
CTLs into the lungs after secondary infection with the H3N2
virus was not observed any earlier than after primary H3N2
infection and even later than after primary H1N1 infection.
Such a delay could be too long for CTLs to make a major
contribution to clearance of the ‘hit-and-run ’ influenza virus. In
line with this idea, it was shown that the CTL response was
capable of handling all but a very low challenge dose of
influenza virus in the absence of antibody (Riberdy et al., 1999).
In the present study, the contact pigs in the Het-I group
showed a similar lymphoproliferation response as the
challenged pigs, but hardly any serum HI antibody response,
anti-M2e antibody response or nasal anti-NP antibody re-
sponse. Therefore, it seems that the contact pigs were indeed
able to cope with the low dose of transmitted virus via a T-cell
response rather than a B-cell response.
An infiltration of NK cells into the lungs was observed
between day 0 and day 15 after primary infection. These cells
probably kill influenza virus-infected epithelial cells in the early
stage of primary infection in a non-specific manner but, at a
later stage of the primary infection, as well as in the early stage
of secondary infection, they are possibly targeted to infected
host cells by antibodies. Anti-M2e MAbs and anti-NA MAbs
that do not have virus-neutralizing activity were suggested to
target effectors of the innate immune system to infected cells
in mice (Mozdzanowska et al., 1999). An influx of CD4+
CD8−/low Th cells was observed between day 0 and day 11 p.i.
CD4+ T cell-mediated recovery from influenza virus infection
was reported to be mediated by the promotion of an antiviral
antibody response (Mozdzanowska et al., 1997 ; Topham &
Doherty, 1998) and a CTL response (Riberdy et al., 2000). In
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addition, CD4+ T cells have been suggested to kill infected
cells in an MHCII-restricted manner (De Bruin et al., 2000 ;
Yasukawa et al., 1988). The role of TCR-cd+ T cells in
protection is unclear. In mice, they have been reported to
increase greatly in frequency during the recovery phase from
influenza pneumonia (Doherty et al., 1989), but this was not
observed in pigs in the present study.
The lymphoproliferation response increased after challenge
in the Het-I group, but not in the Hom-I group. The pigs in the
Hom-I group are probably so well protected that the challenge
virus is cleared from the lungs without inducing a secondary
lymphoproliferation response. The increase in lympho-
proliferation seems to correspond to the increase in the
percentage of CTLs in the lungs, which was also observed only
in the Het-I group. However, in a previous experiment, in
which pigs were primary-infected and then challenged with the
homologous virus 9 weeks later, a secondary lympho-
proliferation response, but no increase in the percentage of
CTLs in the lungs, was observed (unpublished results). In Hom-
I, lymphoproliferation probably mainly supports an antibody
response whereas, in Het-I, it also supports a CTL response.
The lymphoproliferation response was subtype-specific, as it
was higher when PBMC from infected pigs were stimulated
with the homologous virus than with the heterosubtypic virus.
This could be due to the fact that the proliferation depends
partially on T cells and on antigen presentation by B cells that
recognize epitopes of the glycoproteins.
In conclusion, the present study shows Het-I in pigs.
Furthermore, it provides additional evidence for the notion
that cross-reactive antibodies and CTLs both play a role in Het-
I. Het-I provides a much lower level of protection than Hom-
I because antibodies, antigen-presenting B cells, Th cells and
part of the CTLs are subtype-specific and because the less-
protective antibody response to conserved epitopes is low. In
particular, the antibody response to the conserved M2e after
primary infection is suboptimal. This makes M2e an attractive
candidate for vaccine-induced broad-spectrum immunity. Ad-
ditional conserved epitopes to which protective immunity can
be induced may be discovered in the future. Although Het-I
does not provide the complete protection against infection
seen with Hom-I, it caused a pronounced reduction in virus
replication and fever. Prevention of all virus replication after
challenge may not be a realistic goal in cross-protection, but a
significant reduction in virus replication and clinical disease
may well be. For humans, such a level of protection could be
vital in the event that the vaccine strain does not match the
circulating strain or in a future pandemic. For pigs, the level of
protection could be sufficient to prevent virus spread if the
vaccine strain does not match the circulating strain.
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